Treatment with a soluble TM lectin domain reduced cancer cell plasticity in vitro and significantly inhibited melanoma tumor growth and metastasis in vivo.<h4>Conclusions</h4>TM promotes melanoma cell plasticity and VM through FAK- and ezrin-dependent pathways. The gene discussed is PTK2; the disease is melanoma.